Camurus Competitors and Similar CompaniesClear all
Camurus's competitors and similar companies include Avedro, Kamada Pharmaceuticals, Travere Therapeutics and JCR Pharmaceuticals.
 Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. |  Avedro Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals. |  Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. | |
Founding Date | Founding Date 1991 | Founding Date 2002 | Founding Date 1990 | Founding Date 2011 | Founding Date 1975 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB | Locations Waltham, US HQ | Locations Rehovot, IL HQ Beit Kama, IL | Locations San Diego, US HQ Dublin, IE | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP |
Employees | Employees 213 | Employees 122 | Employees 378 | Employees 46293% increase | Employees 934 |
Valuation ($) | Valuation ($) 3.7 b | Valuation ($) N/A | Valuation ($) 307.1 m | Valuation ($) 1.1 b | Valuation ($) 577.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) kr1.7b (FY, 2023) | Revenue (est.) $27.7m (FY, 2018) | Revenue (est.) $142.5m (FY, 2023) | Revenue (est.) $145.2m (FY, 2023) | Revenue (est.) ¥42.9b (FY, 2024) |
Cost of goods | Cost of goods kr108.4m (FY, 2023) | Cost of goods $10.9m (FY, 2018) | Cost of goods $61.7m (FY, 2023) | Cost of goods $11.5m (FY, 2023) | Cost of goods ¥8.4b (FY, 2024) |
Gross profit | Gross profit kr1.6b (FY, 2023) | Gross profit $16.8m (FY, 2018) | Gross profit $80.8m (FY, 2023) | Gross profit $133.8m (FY, 2023) | Gross profit ¥34.4b (FY, 2024) |
Net income | Net income kr431.4m (FY, 2023) | Net income ($25.1m) (FY, 2018) | Net income $8.3m (FY, 2023) | Net income ($111.4m) (FY, 2023) | Net income ¥5.5b (FY, 2024) |
Operating ⚠ | |||||
Clinical Trials | Clinical Trials 25 (FY, 2022) | Clinical Trials 15 (May, 2020) | Clinical Trials N/A | Clinical Trials N/A | Clinical Trials N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 67.6m | Total funding raised $ 90m | Total funding raised $ 25m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Avedro
HQ
Waltham, US
Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals.
View companyKamada Pharmaceuticals
HQ
Rehovot, IL
Employees
378
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyJCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View company